Upregulating lysosome biogenesis in astrocytes by aspirin via the peroxisome proliferator-activated receptor alpha (PPAR)-TFEB pathway was also found to enhance lysosomal degradation of Aβ42 and clearance of Aβ plaque in a mouse AD model [64]. This evidence concerns the gene PPARA and Alzheimer disease.